Valneva
Anders Andersson is a seasoned professional with extensive experience in project management and research within the life sciences sector. Currently serving as a Senior Project Manager at Valneva Sweden AB since September 2019, Anders is leading the development of a new fill-finish vaccine production facility. Previously, as Director of Acturum Biovation at Acturum Development AB, Anders managed a research park dedicated to fostering life science companies and academic collaborations. With a background in AstraZeneca spanning nearly two decades, roles included Associate Principal Scientist and Associate Director, focusing on preclinical MRI research and leading a neurobiology research team. Anders also possesses entrepreneurial experience as the owner of A. Andersson Teknik och utveckling, providing technical consulting in life sciences and project management. Anders holds a Bachelor of Science in Organic Chemistry from Umeå University.
This person is not in any offices
Valneva
3 followers
Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Valneva has leveraged its expertise and capabilities both to successfully commercialize two vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus and COVID-19.